Y-27632, A Rho-Kinase Inhibitor, Inhibits Proliferation and Adrenergic Contraction of Prostatic Smooth Muscle Cells-Reference-Cited by-同舟云学术

Y-27632, A Rho-Kinase Inhibitor, Inhibits Proliferation and Adrenergic Contraction of Prostatic Smooth Muscle Cells

Published:2003-12 Issue:6 Volume:170 Page:2517-2522
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

REES ROWLAND W.¹,FOXWELL NEALE A.¹,RALPH DAVID J.¹,KELL PHIL D.¹,MONCADA SALVADOR¹,CELLEK SELIM¹

Affiliation:

1. From the Wolfson Institute for Biomedical Research, University College London (RWR, NAF, SM, SC) and Institute of Urology, Middlesex Hospital (RWR, DJR, PDK), London, United Kingdom

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference31 articles.

1. Benign prostatic hyperplasia: a review of its histogenesis and natural history;Oesterling;Prostate,1996

2. The development of human benign prostatic hyperplasia with age;Berry;J Urol,1984

3. Alpha-adrenergic mechanisms in dynamics of benign prostatic hypertrophy;Caine;Urology,1988

4. Combination medical therapy for symptomatic benign prostatic hyperplasia;Savage;Can J Urol,1998

5. Combined effect of terazosin and finasteride on apoptosis, cell proliferation, and transforming growth factor-beta expression in benign prostatic hyperplasia;Glasman;Prostate,2001

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging drugs for the treatment of benign prostatic hyperplasia: a 2023 update;Expert Opinion on Emerging Drugs;2024-06-14

2. Mechanism of RhoA regulating benign prostatic hyperplasia: RhoA-ROCK-β-catenin signaling axis and static & dynamic dual roles;Molecular Medicine;2023-10-20

3. Boosting mitochondrial function and metabolism in aging female germ cells with dual ROCK/ROS inhibition;Biomedicine & Pharmacotherapy;2023-07

4. Topographic Orientation of Scaffolds for Tissue Regeneration: Recent Advances in Biomaterial Design and Applications;Biomimetics;2022-09-12

5. “ASSOCIATION OF LOWER URINARY TRACT SYMPTOMS WITH METABOLIC SYNDROME IN MALE PATIENTS OF AGE MORE THAN 45 YEARS.”;GLOBAL JOURNAL FOR RESEARCH ANALYSIS;2021-04-15